B-SOFT Co.,Ltd. (SHE:300451)
3.490
-0.020 (-0.57%)
Sep 30, 2026, 3:04 PM CST
B-SOFT Revenue
B-SOFT had revenue of 257.37M CNY in the quarter ending June 30, 2026, a decrease of -10.11%. This brings the company's revenue in the last twelve months to 929.74M, down -26.94% year-over-year. In the year 2025, B-SOFT had annual revenue of 1.05B, down -26.07%.
Revenue (ttm)
929.74M
Revenue Growth
-26.94%
P/S Ratio
5.82
Revenue / Employee
249.19K
Employees
3,731
Market Cap
5.41B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.05B | -370.92M | -26.07% |
| Dec 31, 2024 | 1.42B | -193.23M | -11.96% |
| Dec 31, 2023 | 1.62B | 88.73M | 5.81% |
| Jan 1, 2023 | 1.53B | -371.84M | -19.58% |
| Jan 1, 2022 | 1.90B | 266.14M | 16.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 51.52B |
| Shenzhen Mindray Bio-Medical Electronics | 34.29B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 31.32B |
| HPGC Renmintongtai Pharmaceutical | 10.64B |
| Hunan Jiudian Pharmaceutical | 2.89B |
| Sichuan Biokin Pharmaceutical | 2.54B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.56B |
| Jiangsu Jibeier Pharmaceutical | 1.00B |